Goelzer Investment Management, Inc. Novartis Ag Transaction History

Goelzer Investment Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $664,063 - $803,221	-8,506 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $2,913 - $3,279	36 Added 0.43%	8,506 $743,000
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $50,882 - $71,287	-720 Reduced 7.83%	8,470 $698,000
Q4 2019 Feb 07, 2020	SELL	$84.35 - $95.37 $42,175 - $47,685	-500 Reduced 5.16%	9,190 $870,000
Q3 2019 Nov 06, 2019	SELL	$85.54 - $94.26 $15,482 - $17,061	-181 Reduced 1.83%	9,690 $842,000
Q2 2019 Jul 29, 2019	BUY	$75.4 - $92.8 $81,507 - $100,316	1,081 Added 12.3%	9,871 $901,000
Q1 2019 May 03, 2019	BUY	$75.32 - $86.15 $662,062 - $757,258	8,790 New	8,790 $845,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Goelzer Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Goelzer Investment Management, Inc. with notifications on news.